Leukemia, Lymphoid: all 1,772 studies
Page 16 of 18. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.
- Urban Environmental Exposures and Childhood CancerCompletedNCT00505141
- R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT00504491Phase 2
- Genetic Study of Chronic Lymphocytic Leukemia FamiliesStatus unknownNCT00503256
- A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)TerminatedNCT00499239Phase 1/2
- A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00496132Phase 1/2
- PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCompletedNCT00494897Phase 4
- Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00489203Phase 2
- Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic LeukemiaWithdrawnNCT00485966Phase 2
- Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage IIICompletedNCT00483132Phase 3
- Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00482352
- Kinetic Biomarker for Chronic Lymphocytic Leukemia PrognosisCompletedNCT00481858
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative TherapyCompletedNCT00469729Phase 2/3
- Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.CompletedNCT00466895Phase 1
- Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaTerminatedNCT00464113Phase 1
- GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00459212Phase 1
- Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor CellsCompletedNCT00458679Phase 1
- Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete RemissionCompletedNCT00458523Phase 2
- A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaCompletedNCT00457782Phase 1
- A Study of Enzastaurin in Patients With LeukemiaCompletedNCT00452257Phase 1
- Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic LeukemiaCompletedNCT00450944Phase 1
- Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by VaccinationCompletedNCT00442130Phase 1
- GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.Status unknownNCT00439920Phase 2
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic LeukemiaCompletedNCT00437060
- A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLLCompletedNCT00435084Phase 1/2
- A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic LeukemiaCompletedNCT00431873Phase 2
- Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AMLTerminatedNCT00430443Phase 1
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00430118Phase 3
- Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine GenerationCompletedNCT00428233Phase 1
- A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic LeukemiaCompletedNCT00419250Phase 1
- Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaTerminatedNCT00416910Phase 3
- Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic LeukemiaCompletedNCT00411541Phase 4
- A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesCompletedNCT00406809Phase 1/2
- Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)TerminatedNCT00391066Phase 2
- Glivec in Ph Positive Lymphoblastic LeukemiaCompletedNCT00388895Phase 2
- A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALLCompletedNCT00384228Phase 1/2
- Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast PhaseCompletedNCT00383474Phase 1
- Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT00377104Phase 1
- STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic LeukemiaCompletedNCT00376467Phase 2
- Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic LeukemiaCompletedNCT00366418Phase 1
- Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte LeukemiaTerminatedNCT00360776Phase 2
- Treatment of Adult ALL With an MRD-directed Programme.CompletedNCT00358072Phase 2
- Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic LeukemiaCompletedNCT00352677Phase 1
- A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)CompletedNCT00349596Phase 1
- Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLWithdrawnNCT00349518Phase 2/3
- Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)CompletedNCT00344825
- Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLLTerminatedNCT00344786Phase 1
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT00343369Not applicable
- Analyses of Human Samples Collected in Clinical TrialsCompletedNCT00339664
- Allogeneic Stem Cell Transplantation in Chronic Lymphocytic LeukemiaStatus unknownNCT00337519Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaCompletedNCT00337246Phase 2
- Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic LeukemiaStatus unknownNCT00336206Not applicable
- Osteoporosis in Children With ALLCompletedNCT00330538
- Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLLCompletedNCT00330252Phase 1
- Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger AdultsCompletedNCT00327678Phase 3
- AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00321724Phase 2
- Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLLTerminatedNCT00319930Phase 1
- Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib MesylateCompletedNCT00316953Phase 1
- Identifying Characteristics of Bone Marrow Failure SyndromesStatus unknownNCT00315419
- Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic LeukemiaCompletedNCT00313079Phase 1
- Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic LeukemiaTerminatedNCT00313053Phase 1
- Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)CompletedNCT00309881Phase 2
- T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell TransplantationTerminatedNCT00306332Phase 3
- VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative DisordersCompletedNCT00304005Phase 1/2
- Sorafenib and Bortezomib in Treating Patients With Advanced CancerCompletedNCT00303797Phase 1
- A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)TerminatedNCT00302861Phase 1/2
- 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic SyndromesCompletedNCT00301938Phase 1
- SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic LeukemiaTerminatedNCT00301769Phase 1
- A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib MesylateCompletedNCT00298987Phase 2
- Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00295841Phase 1
- Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00290004Phase 1/2
- Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic LeukemiaCompletedNCT00289562Phase 1/2
- Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)CompletedNCT00289549Phase 2
- Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in ChildrenCompletedNCT00287105Phase 2
- Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00286780Phase 2
- Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)CompletedNCT00285259Phase 2
- SPC2996 in Chronic Lymphocytic LeukaemiaCompletedNCT00285103Phase 1/2
- A Safety Study in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00283101Phase 1/2
- Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's MacroglobulinemiaCompletedNCT00281983Phase 1/2
- Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic LeukemiaCompletedNCT00281892Phase 3
- Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory AnemiaCompletedNCT00278330Phase 1
- Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic LeukemiaTerminatedNCT00278265Phase 2
- Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaCompletedNCT00278213Phase 2
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic LeukemiaCompletedNCT00276848Phase 3
- Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic LeukemiaCompletedNCT00276809Phase 2
- Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell MalignanciesCompletedNCT00275431Phase 2
- Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaCompletedNCT00275080Phase 1
- Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00275054Phase 3
- Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic LeukemiaCompletedNCT00275015Phase 2
- Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00274989Phase 2
- Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00274963Phase 2
- Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic LeukemiaStatus unknownNCT00271063Phase 1/2
- Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic LeukemiaCompletedNCT00270049Phase 2
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in RemissionCompletedNCT00268528
- Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic LeukemiaTerminatedNCT00265915Phase 2
- Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00262795Phase 3
- Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00262782Phase 3
- Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic MalignanciesCompletedNCT00246662Phase 1
- Safety Study of XL844 in Subjects With Chronic Lymphocytic LeukemiaTerminatedNCT00234481Phase 1
- A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously TreatedCompletedNCT00233506Phase 1